Scigliano Sonia, Pinel Sophie, Poussier Sylvain, Fouyssac Fanny, Plenat Francois, Karcher Gilles, Chastagner Pascal
EA 4001 Radiopotentialisation: de la préclinique à la clinique, Faculté de Médecine, Vandoeuvre-les-Nancy, France.
Int J Oncol. 2008 Jan;32(1):69-77.
Relationship between haemoglobin levels and tumour oxygenation has been already reported. The purpose of this work was to compare in human malignant glioma-bearing mice the sensitivity of two well established techniques of tumour hypoxia assessment, especially their ability to detect expected weak variations of tumour oxygenation status associated to haemoglobin level modifications. The relationship between tumour hypoxia and glucose metabolism was also investigated. Experiments were performed on a human malignant glioma (GBM Nan1) xenografted into nude mice. Twenty-four hours after tumour implantation, animals were randomized into three groups: 'Anaemia' for mice subjected to repeated blood samplings, 'Control', and 'rHuEPO' for mice receiving recombinant human erythropoietin. Once the tumours reached a volume of 300+/-100 mm(3), tumour hypoxia was assessed both using the pO(2)-Histograph, Eppendorftrade mark and the pimonidazole binding assay. Glucose metabolism was evaluated by (18)F-FDG autoradiography and compared with the pimonidazole binding distribution pattern. Repeated blood samplings significantly reduced mean haemoglobin levels (10.9+/-2.0 g/dl), inducing chronic anaemia in mice, while daily administration of rHuEPO led to increase of haemoglobin levels (15.8+/-2.0 g/dl). Oxygenation status evaluated by a microelectrode was worsened in anaemic mice (mean pO(2) in tumour = 6.9+/-0.8 mmHg) and improved in rHuEPO-treated animals (mean pO(2)in tumour = 11.4+/-1.2 mmHg). No correlation was observed between the oxygen-sensitive probe and pimonidazole labelling results: both techniques give different but complementary information about tumour hypoxia. Areas of high pimonidazole binding and areas of high (18)F-FDG uptake superimposed well. Present results confirm that modification of haemoglobin levels leads to alteration of tumour oxygenation status. These variations were detectable using the oxygen-sensitive electrode but not the pimonidazole binding assay. The strong correlation between pimonidazole labelling and (18)F-FDG uptake suggests a positive relationship between hypoxia and increased glucose metabolism in this tumour model.
血红蛋白水平与肿瘤氧合之间的关系已有报道。本研究的目的是在荷人恶性胶质瘤小鼠中比较两种成熟的肿瘤缺氧评估技术的敏感性,特别是它们检测与血红蛋白水平改变相关的肿瘤氧合状态预期微弱变化的能力。还研究了肿瘤缺氧与葡萄糖代谢之间的关系。实验在接种人恶性胶质瘤(GBM Nan1)的裸鼠上进行。肿瘤植入24小时后,将动物随机分为三组:接受重复采血的小鼠为“贫血组”,“对照组”,以及接受重组人促红细胞生成素的小鼠为“rHuEPO组”。一旦肿瘤体积达到300±100 mm³,使用pO₂ - 组织图像仪(Eppendorf商标)和匹莫硝唑结合试验评估肿瘤缺氧情况。通过¹⁸F - FDG放射自显影评估葡萄糖代谢,并与匹莫硝唑结合分布模式进行比较。重复采血显著降低了平均血红蛋白水平(10.9±2.0 g/dl),导致小鼠出现慢性贫血,而每日给予rHuEPO导致血红蛋白水平升高(15.8±2.0 g/dl)。用微电极评估的氧合状态在贫血小鼠中恶化(肿瘤平均pO₂ = 6.9±0.8 mmHg),在rHuEPO治疗的动物中改善(肿瘤平均pO₂ = 11.4±1.2 mmHg)。在氧敏感探针和匹莫硝唑标记结果之间未观察到相关性:两种技术提供了关于肿瘤缺氧的不同但互补的信息。高匹莫硝唑结合区域和高¹⁸F - FDG摄取区域重叠良好。目前的结果证实血红蛋白水平的改变导致肿瘤氧合状态的改变。这些变化可以使用氧敏感电极检测到,但不能用匹莫硝唑结合试验检测到。匹莫硝唑标记与¹⁸F - FDG摄取之间的强相关性表明在该肿瘤模型中缺氧与葡萄糖代谢增加之间存在正相关关系。